HLA-J as a new predictive marker in breast cancer for neoadjuvant chemotherapy

被引：0
|
作者：
Wuerfel, F. M. [1 ]
Wirtz, R. M. [1 ]
Winterhalter, C. [2 ]
De Laco, P. [3 ]
Rosati, M. [3 ]
Veltrup, E. [1 ]
Martoni, A. A. [3 ]
Wuerfel, W. [2 ]
Zamagni, C. [3 ]
机构：
[1] Stratifyer Mol Pathol GmbH, Cologne, Germany
[2] Intellexon GmbH, Pocking, Germany
[3] St Orsola Marcello Malpighi Hosp, Obstet & Gynaecol Unit, Bologna, Italy
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1717881
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P049
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [1] HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer
    Wuerfel, Franziska M.
    Wirtz, Ralph M.
    Winterhalter, Christoph
    Taffurelli, Mario
    Santini, Donatella
    Mandrioli, Anna
    Veltrup, Elke
    Ruebner, Matthias
    Fasching, Peter A.
    Wuerfel, Wolfgang
    Zamagni, Claudio
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (11) : 1123 - 1133
  • [2] Dynamic changes of HLA-J expression during neoadjuvant treatment in ovarian cancer
    Wuerfel, F. M.
    Wirtz, R. M.
    Winterhalter, C.
    De Laco, P.
    Rosati, M.
    Veltrup, E.
    Martoni, A. A.
    Wuerfel, W.
    Zamagni, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E211 - E211
  • [3] Androgen receptor as predictive marker for pathologic complete response in breast cancer with neoadjuvant chemotherapy
    Lee, Eun-Gyeong
    Lee, Dong-Eun
    Han, Jai Hong
    Lee, Seeyoun
    Kang, Han-Sung
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Hyun Hee
    Chae, Hee Jung
    Sim, Sung Hoon
    Lee, Keun Seok
    Jung, So-Youn
    CANCER RESEARCH, 2022, 82 (04)
  • [4] Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
    Skarping, Ida
    Fornvik, Daniel
    Sartor, Hanna
    Heide-Jorgensen, Uffe
    Zackrisson, Sophia
    Borgquist, Signe
    BMC CANCER, 2019, 19 (01)
  • [5] White cell toxicity: A predictive marker for survival after adjuvant and neoadjuvant chemotherapy for breast cancer?
    Pandha, HS
    Ashley, S
    Smith, IE
    BRITISH JOURNAL OF CANCER, 1999, 80 : 12 - 12
  • [6] Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
    Ida Skarping
    Daniel Förnvik
    Hanna Sartor
    Uffe Heide-Jørgensen
    Sophia Zackrisson
    Signe Borgquist
    BMC Cancer, 19
  • [7] The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer
    Pieper, Willi
    Ignatov, Atanas
    Kalinski, Thomas
    Haybaeck, Johannes
    Czapiewski, Piotr
    Nass, Norbert
    CANCER BIOMARKERS, 2021, 32 (02) : 161 - 173
  • [8] Predictive markers of response to neoadjuvant chemotherapy in breast cancer
    Tewari, Mallika
    Krishnamurthy, Arvind
    Shukla, Hari S.
    SURGICAL ONCOLOGY-OXFORD, 2008, 17 (04): : 301 - 311
  • [9] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
  • [10] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
    Acs, Balazs
    Zambo, Veronika
    Vizkeleti, Laura
    Szazs, A. Marcell
    Madaras, Lilla
    Szentmartoni, Gyongyver
    Tokes, Timea
    Molnar, Bela A.
    Molnar, Istvan Artur
    Vari-Kakas, Stefan
    Kulka, Janina
    Tokes, Anna-Maria
    DIAGNOSTIC PATHOLOGY, 2017, 12 : 1 - 12
12345